Solar Foods Oy, Vantaa, Finland.
Labcorp Drug Development, Harrogate, UK.
J Appl Toxicol. 2024 Sep;44(9):1347-1360. doi: 10.1002/jat.4621. Epub 2024 May 10.
One way of limiting the environmental impact of food production and improving food security is to replace part of the animal- or plant-based protein in the human diet with protein sourced from microorganisms. The recently discovered bacterium Xanthobacter sp. SoF1 (VTT-E-193585) grows autotrophically using carbon dioxide gas as the only carbon source, yielding protein-rich biomass that can be processed further into a powder and incorporated into various food products. Since the safety of this microbial protein powder for human consumption had not been previously assessed, its genotoxic potential was evaluated employing three internationally recognized and standardized studies: a bacterial reverse mutation test, an in vitro chromosomal aberration assay in human lymphocytes, and an in vitro micronucleus test in human lymphocytes. No biologically relevant evidence of genotoxicity or mutagenicity was found.
一种限制食物生产的环境影响和提高食物安全性的方法是用微生物来源的蛋白质替代人类饮食中部分动物或植物蛋白。最近发现的黄杆菌属细菌 Xanthobacter sp. SoF1(VTT-E-193585)可以使用二氧化碳气体作为唯一的碳源进行自养生长,产生富含蛋白质的生物质,可以进一步加工成粉末并掺入各种食品中。由于这种微生物蛋白粉以前没有被评估用于人类食用的安全性,因此使用三种国际公认和标准化的研究方法评估了其遗传毒性潜力:细菌回复突变试验、人淋巴细胞体外染色体畸变试验和人淋巴细胞体外微核试验。没有发现遗传毒性或致突变性的生物学相关证据。